Showing results (11-20 of 25) with videos related to
Sort By:
Pageof 3
Zeitschrift Fur Medizinische Physik|January 12, 2022
Investigation of biases in convolutional neural networks for semantic segmentation using performance sensitivity analysisDaniel Güllmar, Nina Jacobsen, Andreas Deistung, et al.Journal of Personalized Medicine|February 25, 2023
Myopia Control with Low-Dose Atropine in European Children: Six-Month Results from a Randomized, Double-Masked, Placebo-Controlled, Multicenter StudyAnders Hvid-Hansen, Nina Jacobsen, Flemming Møller, et al.Journal of Personalized Medicine|February 25, 2023
Reproducibility of Mesopic and Photopic Pupil Sizes in Myopic Children Using a Dedicated Pupillometer with Human-Assisted or Automated ReadingAnders Hvid-Hansen, Per Bækgaard, Nina Jacobsen, et al.Journal of Clinical Medicine|February 25, 2023
Low-Dose Atropine Induces Changes in Ocular Biometrics in Myopic Children: Exploring Temporal Changes by Linear Mixed Models and Contribution to Treatment Effect by Mediation AnalysesAnders Hvid-Hansen, Nina Jacobsen, Jesper Hjortdal, et al.Zeitschrift Fur Medizinische Physik|December 24, 2018
Analysis of intensity normalization for optimal segmentation performance of a fully convolutional neural networkNina Jacobsen, Andreas Deistung, Dagmar Timmann, et al.Ophthalmology and Therapy|October 18, 2024
The Macular Choroidal Thickness in Danish Children with Myopia After Two-Year Low-Dose Atropine and One-Year Wash-Out: A Placebo-Controlled, Randomized Clinical TrialNiklas C Hansen, Anders Hvid-Hansen, Toke Bek, et al.The British Journal of Ophthalmology|March 23, 2025
3-year results of 0.01% and 0.1% loading dose atropine treatment including washout in Danish children with myopia: a placebo-controlled, randomised clinical trialNiklas Hansen, Anders Hvid-Hansen, Flemming Møller, et al.Journal of Personalized Medicine|February 23, 2024
Two-Year Results of 0.01% Atropine Eye Drops and 0.1% Loading Dose for Myopia Progression Reduction in Danish Children: A Placebo-Controlled, Randomized Clinical TrialNiklas Cyril Hansen, Anders Hvid-Hansen, Flemming Møller, et al.BMC Ophthalmology|October 31, 2023
Safety and efficacy of 0.01% and 0.1% low-dose atropine eye drop regimens for reduction of myopia progression in Danish children: a randomized clinical trial examining one-year effect and safetyNiklas Cyril Hansen, Anders Hvid-Hansen, Flemming Møller, et al.Journal of Personalized Medicine|December 24, 2025
Correction: Hansen et al. Two-Year Results of 0.01% Atropine Eye Drops and 0.1% Loading Dose for Myopia Progression Reduction in Danish Children: A Placebo-Controlled, Randomized Clinical Trial. <i>J. Pers. Med.</i> 2024, <i>14</i>, 175Niklas Cyril Hansen, Anders Hvid-Hansen, Flemming Møller, et al.Pageof 3